Protagenic Therapeutics, Inc.

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal …

Biotechnology

US, New York [HQ]

Summary
IR
Fin. Reports
Financials
Leadership & Strategy
Possible Catalysts

H1B/PERM Strategy
Macro
News
Peers Performance
Clinical Trials [Soon]
Industry H&T [Soon]
Patents / Trademarks [Soon]
Relevant Disputes [Soon]

Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

Similar Stocks · Adjusted Close

A quick analysis that compared Protagenic Therapeutics, Inc. (PTIX) to it's peer group.

Peer Group

AVTE CYT RZLT ELDN ZIVO TPST ACRV ANTX Compare Together